AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 261 min read$JCAP

Person Penelope JoAnn sold $5K of JCAP

Person Penelope JoAnn (Chief Commercial Officer) sold 246 shares of Jefferson Capital, Inc. / DE (JCAP) at $22.04 on 2026-08-25.

Original reporting
SEC EDGAR · Person Penelope JoAnn
Published Aug 26, 2026, 11:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 12:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$JCAP
Neutral
high confidence
Mentioned
$JCAP
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JCAPNeutralLow
01

Why it matters

The sale is minor and unlikely to move the stock price.

02

Market read

Routine insider transaction with limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 3/10Novelty 3/10Timing: filed today

Background

SEC Form 4 filing for Jefferson Capital, Inc. (JCAP) reporting an insider sale.

Company-level read

Ticker impact

$JCAPNeutralHigh confidence
Context

Form 4 shows Chief Commercial Officer sold 246 shares for $5,421.84 on 2026-08-25.

Expected impact

Likely negligible price movement.

Evidence & confidence

The transaction size is tiny relative to total shares outstanding; no material change in ownership.

Market effects

Sector

None; insider sale does not affect REIT sector broadly.

Regional

None; limited to company level.

Global

None

Counterpoint

What could challenge this read

Even small insider sales can signal concerns, but no evidence here.

Key entities

  • Company
    Jefferson Capital, Inc.

    Real estate investment trust listed on NYSE.

  • Insider
    Person Penelope JoAnn

    Chief Commercial Officer of Jefferson Capital.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

JCAP insider trading history →

Related articles

SEP 16
$JCAPMedAI 8/10

Jefferson Capital (JCAP) Grows Everywhere, But Costs Are Climbing Faster

Jefferson Capital (JCAP) reported Q2 revenue of $177.5M, up 17.7% YoY, with collections growing 17.7% and deployments up 21.5%. Latin America saw the fastest growth. Operating expenses rose 45.6%, nearly three times revenue growth, driven by higher servicing and legal costs. Net income was $41.3M, or $0.67 per share, with adjusted figures higher. Debt remains a factor, with $226M drawn on its credit facility.

insidermonkey.com3 min
AUG 20
$JCAPHighAI 8/10

Jefferson Capital (JCAP) Q2 2026 Earnings Call Transcript

Jefferson Capital (JCAP) reported Q2 2026 earnings with total collections of $300.9M, up 18% YoY, and portfolio deployments of $152.2M, up 21% YoY. Adjusted EPS remained steady at $0.77, while total revenues rose 16.2% to $177.5M. The company highlighted record forward flow commitments and strong performance from Bluestem and Conn's portfolios. Management also announced entry into the Mexican debt market and added auto finance as a third asset class. Operating expenses increased 45.6% due to hig

fool.com2 min
AUG 13
$JCAPMed

Jefferson Capital, Inc. / DE (JCAP): Results of Operations and Financial Condition

Jefferson Capital, Inc. / DE (JCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. ​ Exhibit 99.1 ​ Jefferson Capital Reports Second Quarter 2026 Results ​ Collections Grow 18% to $300.9 Million and Deployments grow 21% to $152.2 Million Estimated Remaining Collections (“ERC”) up 18% to $3.4 Billion Pre-tax Income of $53.3 Million with Net Income of $41.3 Milli

SEC EDGAR 8-K6 min